Based on the Jubilant Ingrevia Limited stock forecast from 1 analysts, the average analyst target price for Jubilant Ingrevia Limited is INR 497.00 over the next 12 months. Jubilant Ingrevia Limited’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Jubilant Ingrevia Limited is Slightly Bearish, which is based on 5 positive signals and 9 negative signals. At the last closing, Jubilant Ingrevia Limited’s stock price was INR 555.45. Jubilant Ingrevia Limited’s stock price has changed by +3.17% over the past week, +20.78% over the past month and +37.66% over the last year.
No recent analyst target price found for Jubilant Ingrevia Limited
No recent average analyst rating found for Jubilant Ingrevia Limited
Company Overview Jubilant Ingrevia Limited
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical intermediates. The Specialty Chemicals segment offers pyridine and picolines, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company also offers cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, dione salts, alkyl pyridines, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, and ethanol. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India. Read Less
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical intermediates. The Specialty Chemicals segment offers pyridine and picolines, fine c...Read More
Frequently Asked Questions About Jubilant Ingrevia Limited (JUBLINGREA:NSE) Stock
Based on ratings from 1 analysts Jubilant Ingrevia Limited's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has buy, sell and 1 hold ratings.
JUBLINGREA:NSE stock's dividend yield is 0.93%.
Our analysis grades JUBLINGREA:NSE stock's dividend yield at D+. This means that JUBLINGREA:NSE stock's dividend yield is above 68% of the stocks in the Specialty Chemicals sector in the NSE exchange.
Based on this JUBLINGREA:NSE may be a average dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for JUBLINGREA:NSE is INR 497.00 over the next 12 months. The maximum analyst target price is INR 497 while the minimum anlayst target price is INR 497.
JUBLINGREA:NSE stock's Price/Earning ratio is 41.31.
Our analysis grades JUBLINGREA:NSE stock's Price / Earning ratio at F. This means that JUBLINGREA:NSE stock's Price/Earning ratio is above 52% of the stocks in the Specialty Chemicals sector in the NSE exchange.
Based on this JUBLINGREA:NSE may be a overvalued for its sector.
The last closing price of JUBLINGREA:NSE's stock was INR 555.45.
The most recent market capitalization for JUBLINGREA:NSE is INR 85.00B.
Based on targets from 1 analysts, the average taret price for JUBLINGREA:NSE is projected at INR 497.00 over the next 12 months.
This means that JUBLINGREA:NSE's stock price may go down by -10.52% over the next 12 months.
We can't find any ETFs which contains Jubilant Ingrevia Limited's stock.
As per our most recent records Jubilant Ingrevia Limited has 2,295 Employees.
Jubilant Ingrevia Limited's registered address is 1A, Sector 16A, Noida, India, 201301.
You can get more information about it from Jubilant Ingrevia Limited's website at https://jubilantingrevia.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for JUBLINGREA:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
